Literature DB >> 16461761

Marburg I polymorphism of factor VII-activating protease and risk of venous thromboembolism.

Franca Franchi, Ida Martinelli, Eugenia Biguzzi, Paolo Bucciarelli, Pier Mannuccio Mannucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16461761     DOI： 10.1182/blood-2005-09-3603

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.

Authors:  Sandip M Kanse; Paul J Declerck; Wolfram Ruf; George Broze; Michael Etscheid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

2.  Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.

Authors:  Sudheer Kumar Gara; Li Jia; Maria J Merino; Sunita K Agarwal; Lisa Zhang; Maggie Cam; Dhaval Patel; Electron Kebebew
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245

3.  Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer.

Authors:  Glenn S Gerhard; Darrin V Bann; James Broach; David Goldenberg
Journal:  NPJ Genom Med       Date:  2017-03-28       Impact factor: 8.617

4.  Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity.

Authors:  M Olsson; T M Stanne; A Pedersen; E Lorentzen; E Kara; A Martinez-Palacian; N P Rønnow Sand; A F Jacobsen; P M Sandset; J J Sidelmann; G Engström; O Melander; S M Kanse; C Jern
Journal:  J Thromb Haemost       Date:  2018-08-24       Impact factor: 5.824
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.